Neuro 2 - Stroke & Meningitis

Acute Ischemic Stroke (AIS)

notion image
  • Incidence of A.I.S is 85% of total cases of stroke.
  • Other 15% is hemorrhagic.
  • Main source: Cardioembolic.

Causes of Clot Formation

  • Atrial fibrillation (commonest cause of cardioembolic clot formation).
  • Atherosclerosis of internal carotid artery.

Rare cause:

  • CADASIL
    • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
    • It has a genetic basis.
    • Gene involved is NOTCH 3 Gene
    • Cadasil → Kaadu → 3 notch

Transient Ischemic Attack (TIA)

  • Sudden onset neurological symptoms that resolve within 24 hours
  • In the majority of cases spontaneous resolution occurs within 1 hour
  • CT head is normal
  • Highest chance of stroke after TIA
    • 48 hours

Score to Predict Risk

  • Score to predict risk of stroke after TIA in next 3 months:
    • ABCD2 score.
  • Maximum score is 7.
    • If the score is 7
      • 22% chances of development of stroke within 3 months

ABCD2

  • A: Age >60 ———————————————————> 1
  • B: BP >140/90 mmHg ———————————————————> 1
  • C: Clinical features:
    • Unilateral weakness ———————————————————> 2
    • Speech disturbance without weakness ———————————————————> 1
  • D2:
    • Duration
      • > 60 minutes ———————————————————> 2
      • 10-59 minutes ———————————————————> 1
    • Diabetes mellitus ———————————————————> 1

Treatment of TIA

  • Dual antiplatelet therapy:
    • Drugs used are Aspirin and Ticagrelor.
    • Note:
      • given in MI (both STEMI and NSTEMI),
      • in a patient undergone PCI with stenting
      • in CABG patient.
    • Ticagrelor
      • CYP2Y12 inhibitor.
    • Prasugrel has more chance of bleeding
    • Clopidogrel is not preferred in Asians
      • not metabolized in active form.
      • exhibits CYP2C19 polymorphism.
  • Statins:
    • For hypercholesterolemia.
  • Control hypertension.
    • Long-term target of BP
      • TIA <120 mmHg
        • Recent update
        • SPRINT TRIAL
        • Sprinted 120m → TIA came
    • Immediate target of BP
      • <130/80 mmHg.

Important Information

  • In a patient of rheumatic heart disease
    • mitral stenosis + atrial fibrillation + TIA
      • WARFARIN
        • NOT NOAC
        • lower TIA risk
  • TIA + ICA atheroscelorisis
    • NOAC can be given

Thrombolysis in Acute Ischemic Stroke

Radiological finding

notion image
  • Non contrast CT head:
    • Normal (in majority cases).
    • to rule out haemorrhagic stroke
  • Thrombolysis can cause increased bleeding risk.
  • Hyperdense MCA sign
    • Early clot in MCA appears hyperdense
    • uncommon
    • Laterhypodensity.
      • notion image
  • Blackish hypodensity
    • which develops over time.
    • Ischemic damage
  • Acute stroke
      1. White → s/o Acute hemorrhage/clot
      1. Well-defined hypodense infarct in MCA region.
      1. Hypodensity in thalamus: Lacunar infarct
          • Charcot's artery/ LS branch of MCA
            • notion image
  • White artery (MCA)Hyperdense artery signAcute thrombus
    • notion image
  • Loss of insular ribbon:

      • In MCA strokeinsular cortex becomes oedematous first
      • because of its closest proximity to Lateral sulcus
        • notion image
          notion image

  • DWI: Restricted diffusion S/O acute infarct.
    • notion image
    • Chronic infarct: No restricted diffusion (due to CSF).

Moya Moya disease

notion image
 
Angio
Angio
  • On DSA, ICA is shown.
  • Due to ICA stenosis and collateral development.
    • Black narrowed vessels are seen.
    • Contrast appears as a puff of smoke.

Thrombolysis window:

  • 4.5–6 hours.
    • USA:
      • Indicated up to 3 hours.
    • Canada, UK:
      • Up to 4.5 hours.
    • Harrison:
      • Some benefit up to 6 hours.

After 6 hours (up to 24 hours):

  • Mechanical thrombectomy.

Indications for thrombolysis

  • Clinical diagnosis of stroke.
  • Symptom onset to drug < 4.5 hours ???
  • CT:
    • No hemorrhage
    • No edema >1/3 MCA territory.
  • Age >18 years.

Contraindications for thrombolysis

  • BP > 185/110 mmHg despite labetalol/nicardipine.
  • Bleeding diathesis (INR > 1.7).
  • Recent head injury or intracerebral bleed.
  • Major surgery in preceding 14 days
  • GI bleeding preceeding 21 days
  • Recent MI

Action plan for management of stroke (Harrison 21st edition update):

notion image
notion image
  • Prehospital: Call ahead, activate Code stroke.

Onset <6 h: (“Last seen well” is used for calculation)

  • CT: No hemorrhage.
  • IV PA eligible?
    • If yes: Give IV PA.
      • Alteplase → Bolus f/b infusion
      • At CT scan: Tenecteplase Single bolus
    • If Not: Perform CT angiography
      • Detects Emergent large vessel occlusion (ELVO).
      • ICA or M 1-2 of MCA or Basilary Artery occlusion?
      • If ELVO present → do CT Perfusion
        • checks penumbra vs ischemic core mismatch.
        • helps pick up penumbra.
          • Viable ischemic areas that can be saved.
        • If yes: Consider Mechanical ThrombectomyMERCI
        • notion image

Onset 6–24 h:

  • CT: No hemorrhage.
  • CTA/CTP: Favorable perfusion?
    • If yes: Thrombectomy MERCI

Role of MRI (DWI)

  • Most sensitive than NCCT for early infarct.
  • Not preferred (time, cost, limited availability).

Management in any patient of acute ischemic stroke:

  • Assess airway.
  • Control BP.
  • Record last known normal time.
  • NIHSS: Assess stroke severity.
    • If NIHSS >35:
      • Thrombolysis.
      • Endovascular therapy (MERCI).
  • After acute stroke managed:
    • Aspirin
      • after first 24 hours to prevent recurrence and mortality.
      • Continue aspirin 75–81 mg lifelong (Harrison: 81 mg).
    • Ticagrelor:
      • 180 mg load, 90 mg BID after.
        • Upto 1 month;
    • DAPT (aspirin + ticagrelor):
      • 1 month
      • to reduce reinfarction.
    • Statins.
    • Apixaban: For atrial fibrillation.
      • Warfarin for rheumatic heart disease, mitral stenosis.
    • Carotid endarterectomy: If atherosclerotic narrowing of ICA.
  • Target systolic BP:
      1. Initially 130/140 mmHg for cerebral perfusion.
          • Cerebral perfusion = MAP – ICP.
      1. After recovery
          • BP <120 mmHg (Harrison update).

STROKE LOCALISATION

Brain Areas and Blood Supply

Area
Blood Supply
Broca’s area (44, 45)
MCA
Wernicke’s area (22, 39, 40)
MCA
Visual cortex (17, 18, 19)
PCA
Lower limb (sensory & motor)
ACA
Paracentral lobule
ACA

Applied Aspect

  • ACA stroke:
    • Causes C/L LL paralysis
    • Incontinence.

ACA stroke

  • Paracentral Lobule
    • Urinary incontinence
    • C/L paralysis and sensory loss: lower limb
    • Highest centre for micturition & defecation
  • Personality changes

MCA Dominant

  • Dominant (Left Side) Parietal Lobe
    • C/L paralysis and sensory loss: face and upper limb
    • Aphasia
      • Talk dominantly
  • Non-dominant (Right side) Parietal Lobe
    • C/L paralysis and sensory loss: face and upper limb
    • HEMINEGLECT
      • Neglect non dominant side
      • notion image

PCA Stroke

  • C/L hemianopia
  • Anton Syndrome
    • Denial of blindness + Confabulation
  • Alexia without agraphia (Dominant)
    • Linked to Splenium

Thalamic Stroke

  • C/L hemisensory loss followed by an agonizing, burning pain in the affected areas
    • Djerine - Rowsy Sx

Additional Signs & Localisation

  • Parietal Lobe Functions
    • notion image
    • Stereognosis
    • Graphesthesia
    • Simultagnosia
      • Finds small 'A's but misses big ones
  • Fusiform Gyrus (Temporo-occipital lobe)
    • Prosopagnosia
      • Inability to recall identical faces
      notion image

Various Scenarios of Intracranial Hemorrhage

Circle of Willis

notion image
notion image
notion image
notion image
  • Note: Middle cerebral artery does not form the Circle of Willis.
  • Labyrinthine artery: Branch of AICA
  • Ophthalmic artery: 1st branch of ICA
  • Internal carotid: main brain supply.
  • Posterior cerebral artery: From basilar artery.

Meningitis

Lumbar puncture

notion image
  • L3-L4 or L4-L5;
    • choose widest space.
notion image

Indications of CT before Lumbar Puncture: FAILS

  • Focal neurological deficit
  • Altered mental status
  • Immuno-compromised
  • Lesion
  • Seizure
  • Papilledema

Needles

  • Dura cutting:
    • Increased Post Dural Puncture Headache (PDPH).
    • Pointed edge
    • Technically easier.
    • Examples: Quincke (most common).
      • notion image
    • Mnemonic: Kuttunnath → quincke
  • Dura splitting:
    • Decreased PDPH.
    • less traumatic
    • Technically difficult.
    • Examples: Whitacre, Sprotte
      • notion image
    • Mnemonic: Wisely (Whitacre Sprotte) Split
  • Steps
    • Advance needle cephalad (bevel up).
  • After CSF appears
    • re-insert stylet halfway to prevent herniation.

Meningitis cause in Neonates

  • Escherichia coli (most common)
    • 0 - 2 months
  • Group B Streptococcus (most common)
    • > 2 months
  • Listeria monocytogenes
    • PALCAM media,
    • tumbling motility
    • treat with ampicillin

Meningitis cause in Children, Adults, and Elderly

  • Streptococcus pneumoniae (most common)
  • Neisseria meningitidis (meningococcus)
  • Haemophilus influenzae type B (Hib)
    • risk of deafness if no Hib vaccine

CSF tubes

Tube
Purpose
Collected CSF (mL)
1
Glucose, protein (biochemistry)
0.5
2
Cell count, DC (hematology)
1
3
Gram stain, CSF culture

Latex agglutination (Immunology)
• partially treated case of meningitis if required
2 - 5
4
Hold for repeat (in storage facility at 37°C)

Meningitis in a child

Clinical features

  • Fever.
  • Headache.
  • Seizures.
  • Nuchal rigidity.
  • Vomiting (if ICP is raised).
  • Sleepiness, irritability.
  • Delirium (if undiagnosed).
  • Focal neurological signs may be seen.
  • Altered sensorium/encephalopathy.
  • Anorexia.
  • Infant:
    • Non-specific features:
      • Poor feeding.
      • Lethargy.
      • Irritability with shrill cry.
      • Petechiae.
      • Purpura.
  • Older children (12-18 months of age:):
    • headache.
    • Photophobia.
    • Myalgia & arthralgia.
    • Blurring of vision.
    • Diplopia.

Signs of meningeal irritation

  • Neck rigidity.
  • Meningeal signs:
    • Kernig's sign,
    • Brudzinski' sign.
  • Younger infants:
    • Tense Bulging fontanelle.
    • Widening of sutures.

Examination

notion image
  • AMOSS sign/Tripod sign.
    • notion image
  • Nuchal rigidity:
    • Ask patient to touch chin to chest.
  • Kernig sign:
    • Mnemonic: Knee extension → Kernig
    • Supine, extend leg at knee (pain in hamstrings or back).
  • Brudzinski sign
    • Neck flexion
      • passive flexion of hip and knee,
  • Jolt accentuation test:
    • Turn head side-to-side rapidly; increases pain.
      • False positives in headache patients.

Fundus examination:

  • Papilledema.

Workup

  • Blood culture for hematogenous spread.
  • Start empirical antibiotics within 1 hour.
    • Does not affect CSF findings.
  • NCCT done before LP
    • exclude raised ICP/midline shift.

NOTE

  • In meningitis, empirical prophylaxis
    • Vancomycin (G +ve) + Ceftriaxone (G -ve)
    • In extremes of ages → also add Ampicillin (for listeria)

Treatment:

  • Isolate Till 24 hours after starting antibiotics
  • Prompt initiation of empirical antibiotics.
  • IV 3rd gen. cephalosporin (ceftriaxone)
    • Child: 7-10 days
    • Neonate: 3 weeks
    • No response in 48 hours
      • Add vancomycin
  • Steroids Along with first dose of IV antibiotics.
    • DOC : Dexamethasone x 2 days
      • goal : ↓↓ incidence of SNHL.
  • Duration
    • Streptococcal meningitis:
      • 7–10 days
    • Gram-negative meningitis (excluding neonatal cases):
      • 3 weeks
    • Staphylococcal meningitis:
      • 3 weeks
    • Meningococcal meningitis:
      • 7 days
      • Prophylaxis of Meningococcal meningitis
        • Ceftriaxone
          • Safe in
            • pregnancy
            • In childrens
        • Rifampicin
          • Safe in childrens
          • For 2 days
          • Not in pregnancy
        • Ciprofloxacin
          • Not in
            • pregnancy
            • In childrens

Complication

  • SNHL in Children
  • Often follows S. pneumoniae-associated meningitis
  • Investigation: Brain evoked response audiometry (BERA)
notion image

CASE

  • Immunocompromised history ⇒
    • Cryptococcosis

CASE

  • Q. With immunocompromised history ⇒
    • Pneumococcus if
    • Diagnosis
        1. Gram-positive diplococcus.
        1. India ink positive.
          1. ?????
            ?????
    • Treat with antibiotics.

CASE

notion image
  • CSF: Cobweb coagulum.
  • Diagnosis: Tubercular meningitis.
  • Weeks-long history, gradual onset, hydrocephalus may occur in kids.
  • CSF:
    • Lymphocytic pleocytosis,
    • low sugar,
    • V. high protein.
  • Bacterial meningitis:
    • CSF
      • Marked sugar drop (hypoglycorrhachia).
      • Neutrophils seen.
  • CSF protein:
    • Normal:
      • 15–45 mg%,
    • in TBM:
      • 10–20 × norm.
  • Normal CSF sugar:
    • >2/3 blood sugar.

CSF findings summary table

Disease
Appearance
Cells
Sugar
Protein
Acute Bacterial meningitis

Pneumococcus
(all ages)
Turbid
>1000 PMN
(0-4 normal)
↓↓ = 0
(Hypoglycorrhachia)
↑↑
TBM
(
Tubercular meningitis)
Straw coloured
>100 lymphs
↓ ↓
Cobweb ↑↑
Viral meningitis (enterovirus)
Clear
>20 lymphs
Normal
GBS
Clear
0-4 lymphs
Normal

Albumin-cytologic dissociation

Aseptic Meningitis

notion image
  • Clinical sign:
    • AMOSS/Tripod sign.
      • On sitting up,
          1. flexes knees/hips,
          1. props up,
          1. flexes spine.
  • Causes:
    • Infectious
      • Viral meningitis
        • M/c enterovirus (90%)
        • HSV 2
      • Mollaret meningitis
        • HSV-1 (typically above waist)
          HSV-2 (typically below waist)
          Primary Transmission
          Mucosal or abraded skin contact
          Sexual contact
          Vertical
          Site of Latency
          Trigeminal ganglia
          Sacral ganglia
          M/c Age of Primary Infection
          Childhood
          Sexually active adults
          Classic Clinical Presentations
          Orofacial herpes (cold sores)
          Herpetic gingivostomatitis
          Herpes labialis
          • Skin lesions above waist
          (herpes gladiatorum, eczema herpeticum)
          Herpes encephalitis
          Genital herpes
          • Skin lesions below waist
          Neonatal herpes
          Aseptic meningitis (Mollaret’s)
    • Non infectious
      • ibuprofen
      • Sjogren.
      • TMP/SMX
      • ciprofloxacin
  • Gram stain: Negative.
  • Culture: Negative.
    • No pyogenic organism found.
  • RBC may be present in CSF - HSV

Cysticercosis

notion image
  • Routes: Important
      1. Pork
          • larvae intestinal tapeworm.
      1. Vegetables on contaminated soil (like cabbage)
          • eggs neurocysticercosis.
  • Cysticercosis:
    • Rice-grain calcification (dead larvae).
      • Alternative: Steroids, Praziquantel.

Neurocysticercosis

notion image
  • Soli sir affect brain → he is sole cause (sub kuch infective - egg and larvae) → Nakshathram enni (starry sky)
    • he was Para (Parenchyma brain)
    • solium - systi sercus sellulose → inside the cell
  • Cysticercus cellulosae:
    • zig-zag tube, hooklets, suckers, convoluted tube-like structure
    • notion image
  • Scolex in brain.
  • M/C site : Brain parenchyma
  • M/C presentation: Seizures
  • Imaging: Gadolinium MRI preferred.
    • Starry sky appearance
  • Drugs: Steroids f/b Albendazole (DOC)
    • ↓ inflammation d/t dying larvae

Clinical features

  • Low socioeconomic status.
  • Multiple focal seizures.
    • Vasogenic cerebral oedema can cause focal seizures.

General exam

  • Multiple subcutaneous lumps/bumps.

First:

  • LP (guarded)
    • CSF immunoblot for NCC antigen
    • (NOTE: CSF ELISA is for cryptococcus)

NCCT

  • Starry sky appearance d/t calcification
    • But not early on CT.
    • notion image
      NCC with single brain lesion
      NCC with single brain lesion
      notion image
    • Cyst with a dot inside (scolex).
    • End stage: can be calcified.
      • Starry sky appearance.
    • Can spread to muscles.
      • Rice grain calcification.
    • Can cause hydrocephalus.

Imaging:

  • Gd-MRI.
  • Vasogenic cerebral edema

Stages of Lesion in Radiology

Stages
Features
1
Vesicular
Hypointense lesion
white dot in black circle.
2
Colloidal vesicular
Perilesional edema → Seizures
3
Nodular vesicular
↑ cerebral edemarecurrent epsodes → not responding
4
Nodular calcified
Immunity destry the worm → calcification

Treatment of NCC

  1. Start dexamethasone (48h) to control edema.
  1. Albendazole
      • not started first because
        • prevents inflammatory reaction
        • ↑ seizures
  1. CBZ/Lamotrigine: For seizures.

Ring-enhancing lesion DDx

  1. Neurocysticercosis.
  1. Tuberculoma.

MR Spectroscopy

notion image
  • Creates a graph of chemical metabolites.
    • Condition
      Maximum Peak
      Normal brain
      NAA
      Tumor
      Choline
      Tuberculosis
      Single lipid peak + basal exudates
      Neurocysticercosis
      Multiple amino acid peaks.

Comparison Table

notion image
Feature
Neurocysticercosis
Tuberculoma
Size
<20mm, single/multiple
>20mm, multiple, conglomerated
Associated meningitis
Absent
Present (meningitis findings)
Site
Gray-white jxn
post fossa
MR spectroscopy
Amino acid peaks
Lipid peaks (M. tuberculosis)
FND
Absent
Present
Raised ICP
Transient
Present
Constitutional symptoms
Absent
Present

Cryptococcal Meningitis

notion image
  • New world
    • Pigeon droppings + Immunodeficient people
    • Easily treatable
    • + Negative (India ink) Music (Mucicarmine)
  • Old world → Gatti
    • Trees (eucalyptus tree) with leaf (LFA) and latex
    • immunocompetent + Immunodeficient people
    • Tropical climate
    • difficult to treat diseases

Clinical features

  • Fever, headache, photophobia, vomiting, nuchal rigidity.
  • Seen in immunocompromised,
    • e.g. AIDS truck driver.

Workup

  • First:
    • Blood culture,
    • start empiric antibiotics in 1 hr.
  • Empiric:
    • Ceftriaxone + vancomycin (no cryptococcal coverage).
  • NCCT:
    • Check raised ICP.
  • Brain biopsy:
    • In dead
    • Mucicarmine
  • CD4 <100 needed for disease.

LP:

  • CSF cell counts.
    • Lymphocytic pleocytosis.
  • Slightly reduced sugar, high protein (norm: 15–45 mg%)
  • Gram: No organism.
  • CSF ELISA (Ag) is IOC.
  • India ink / Nigrosin:
    • Positive > Negative (not reliable).
      • notion image

Culture

  • Agar: Bird seed / Niger seed agar
  • Colour: Brownish due to Phenol Oxidase / Laccase
notion image

Confirmatory Test

notion image
  • Lateral flow assay > latex agglutination
    • Lateral flow assay cryptococcal antigen
      • Serum/plasma/CSF.
      • More sensitive and specific
    • Latex agglutinationGlucuronoxylomannan
  • Cryptococcus found in pigeon droppings, dust.
    • Healthy:
      • No CNS disease due to immunity.
    • Immunosuppressed:
      • Lungbrain (via blood)

Treatment

  • Amphotericin B >> (+) flucytosine
    • Not LAMB (For Kala azar)
  • Prevention/Maintenance
    • Fluconazole (when CD4 < 100)
notion image

AMB

  • Side effects
    • Nephrotoxic
      • Liposomal AMB is less nephrotoxic.
      • (Cryptococcal, Mucor uses AMP)
    • Infusion reaction
    • RTA type 1
    • Hypokalemia
    • BM suppression

Guillain Barre Syndrome

  • GBS is an 
    • acute onset (≤4 weeks)
    • bilateral symmetrical
    • inflammatory
    • autoimmune polyradiculoneuropathy.
  • Autoimmune Demyelination of peripheral nervous system.
  • Ascending, symmetrical, flaccid paralysis.
  • 7th cranial nerve is most commonly involved
  • Bladder and bowel spared (if involved → transverse myelitis)
  • GBS is usually post-infectious (2-3 weeks).
    • A/w Campylobacter
  • AIDP is most common GBS.
  • Antibody: Anti GM1 Antibody.
    • NOTE:
      • Miller Fisher: Anti GQ1 Antibody.
      • Mnemonic: Fish vangan Que nikkanam
  • Brighton criteria for diagnosis.
    • NOTE: Revised McDonald criteria for Multiple sclerosis.

Pathophysiology

2 → Myelination
2 → Myelination
  • IgG AntibodiesBind to Myelin/Axons → Activates complement → Macrophage invasion → Vesicular degeneration

Inciting Factors/Triggers

  • Gastroenteritis/URTI (Past 4 weeks):
    • Present in 60-70% of GBS cases.
  • Campylobacter jejuni (Most common trigger)
    • Molecular mimicry implicated.
  • CMV (Cytomegalovirus)
  • EBV (Epstein-Barr Virus)
  • Mycoplasma
  • Hep A/B
  • HIV
  • Zika virus
  • Vaccination associated.
Note: 
  • C. jejuni also A/w
    • IPSID- Immunoproliferative Small Intestinal Disease/Lymphoma

Features:

  • Earliest sign: Distal areflexia.
  • Bilateral ascending symmetrical flaccid paralysis.
    • Maximum severity of 2 weeks after initial onset
  • B/L atonic areflexic paraparesis (Proximal > distal) of lower limbs.
  • Equal paralysis of both legs
    • quadriplegia
  • Neuropathic pain, particularly in the legs
    • Large fibre () sensory loss.
  • Truncal paralysis
    • Cant sit up in the bed
  • Cervical demyelination
    • respiratory paralysis
  • Neck floppiness.
  • 7th nerve palsy (facial diplegia) → M/c CN involved
  • In severe cases ➔ Respiratory failure ➔ FVC should be done to assess ventilation

Brighton Criteria for GBS

  • Bilateral and flaccid limb weakness.
  • Decreased/absent deep tendon reflexes in weak limbs.
  • Monophasic course;
    • onset 12 hours to 28 days.
  • No alternative diagnosis for weakness.
  • Albumino-cytological dissociation
  • Nerve conduction:
    • consistent with GBS (latency increased).

Prognosis

  • 80% recover.
    • Begins 2-4 weeks after progression ceases.
  • 4-15% mortality.

Bad Prognostic Factors

  • Autonomic Nervous System
    • Labile hypertension (Extreme BP fluctuations).
    • Postural hypotension (Orthostatic hypotension).
    • Arrhythmias.
    • Anhidrosis.
    • Tachycardia.

Typical Electrodiagnostic Features (NCS)

  • Prolonged latency.
  • Decreased conduction velocity.
  • Conduction block.
  • Absent/prolonged F-wave & H-reflex.
  • Temporal dispersion.

LP: Albumino-cytological dissociation.

  • CSF cells < 50/ml
  • CSF protein concentration > 60 mg/dL.
  • CSF opening pressure: normal.
  • Sugar: normal.
  • Color: normal.

Treatment

  • DOC: IV Immunoglobulins.
  • PlasmapheresisPLEX (Plasma Exchange) Therapy
  • Both therapies equally effective.
  • No role for steroids.

DD

  • Transverse myelitis vs GBS
    • Bladder/bowel involvement.
    • Root pain.
    • Urinary incontinence.

Comparison Table

notion image
Note:
  • CIDP (Chronic Inflammatory Demyelinating Polyneuropathy):
    • Chronic, >8 weeks.

Classification

  • All antibodies associated are IgGs.
Subtype
Features
Electrodiagnosis / Pathology
Prognosis
Antibodies Associated
Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
Most common Monophasic illness:
duration
4 weeks.
Demyelinating
Best prognosis of all types.
Anti-GM1 antibodies ??
Acute Motor Axonal Neuropathy (AMAN)
Children & young adults.
Axonal
Poor prognosis.
Anti-GD1a antibodies ??
Acute Motor Sensory Axonal Neuropathy (AMSAN)
Mostly adults. Severe axonal pathology
Axonal + sensory loss.
Poor prognosis.
Miller Fisher Syndrome (MFS) (Rarest form)
Clinical Triad:
1. Ophthalomplegia
2.
Ataxia
3.
Areflexia
Axonal or Demyelinating
Anti-GQ1b antibodies

Kerala Nipah Outbreak

notion image
notion image
notion image
 
  • Kerala:
    • Nipah virus (NiV) 2018 caused outbreak.
    • Enveloped Non-segmented RNA Virus
    • Paramyxovirus
  • Causes encephalitis ± ARDS.
  • Route: Human-to-human via secretions.
  • Clinical: Encephalitis, fever
  • Mortality rate: 60 - 80%
  • Infection by:
    • Reservoir: Fruit Bat genus → Pteropus.
      • primary vector
      • Bat urine/saliva/feces contaminates date palm sap
      • Contaminated fruit eaten by pigpig to human/pork exported.
        • Pigs = amplifiers
      • Virus also in patient secretions
  • No treatment exists.
  • To diagnose: PCR of CSF for Nipah.

Primary Amoebic Meningoencephalitis (PAM)

notion image
 
  • CSF: Neutrophils, motile trophozoite
  • Cause: Naegleria fowleri via nose.
  • Swimming pond/stagnant water exposure.
  • Rarely swimming pool.
    • Nasal route → cribriform plate → brain
  • Causes meningitis + encephalitis symptoms.
  • Manage:
    • Liposomal amphotericin B,
    • Rifampicin
    • Corifungin

Mollaret Meningitis

notion image
  • CSF: Monocytes, clefted nuclei (Mollaret cells).
  • Variant of aseptic meningitis.
  • Virus: HSV-2.
    • Causes recurrent aseptic meningitis.

Leading viral encephalitis

  • India: Japanese B.
  • worldwide: Herpes simplex.